HEALTH CARE SECTOR

 » 

HEALTH CARE EQUIPMENT & SUPPLIES INDUSTRY

 » 

MASI

masimo corporation (MASI:NASDAQ GS)

Last $21.71 USD
Change Today -0.13 / -0.60%
Volume 206.0K
MASI On Other Exchanges
Symbol
Exchange
MASI:US
NASDAQ GS
3M4:GR
Berlin
As of 8:10 PM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Key News About masimo corporation

From Bloomberg From Businessweek From Around the Web Show All
Form 4 MASIMO CORP For: May 22 Filed by: Coleman Robert
US Securities and Exchange Commission - 05/24/2013 7:08 PM ET
El Paso Children's Hospital Standardizes to Masimo SET® Pulse Oximetry
PR Newswire - 05/23/2013 8:00 AM ET
Study Shows Noninvasive SpCO® Can Help Rapidly Detect Carbon Monoxide Poisoning in the Emergency Department
PR Newswire - 05/21/2013 10:45 AM ET
Masimo CEO Joe Kiani Receives Argyros Medal for Visionary Leadership & Commitment to Patient Safety
PR Newswire - 05/20/2013 8:04 PM ET
New Clinical Study Finds Masimo rainbow® Acoustic Monitoring™ Technology More Accurately, Precisely, and Reliably Detects Ventilatory Pauses in Post-Surgical Patients
PR Newswire - 05/16/2013 8:00 AM ET
New Published Clinical Study Shows Masimo PVI® Helps Clinicians Assess Fluid Responsiveness in Pediatric Patients
PR Newswire - 05/15/2013 8:00 AM ET
New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb®, RRa™, and SedLine®
PR Newswire - 05/13/2013 8:00 AM ET
Form 10-Q MASIMO CORP For: Mar 30
US Securities and Exchange Commission - 05/08/2013 5:04 PM ET
Uludag University Hospital Installs Masimo Noninvasive rainbow® Technology to Improve Patient Assessments and Speed Clinical Decisions
PR Newswire - 05/08/2013 8:00 AM ET
Uludag University Hospital Installs Masimo Noninvasive rainbow® Technology to Improve Patient Assessments and Speed Clinical Decisions
PR Newswire - 05/08/2013 8:00 AM ET
FDA Clears Masimo rainbow® Acoustic Monitoring™ Sensor for Use on Pediatric Patients
PR Newswire - 05/06/2013 8:00 AM ET
Form 8-K MASIMO CORP For: May 02
US Securities and Exchange Commission - 05/02/2013 4:08 PM ET
Masimo Reports First Quarter 2013 Financial Results
PR Newswire - 05/02/2013 4:05 PM ET
Form 10-K/A MASIMO CORP For: Dec 29
US Securities and Exchange Commission - 04/29/2013 4:05 PM ET
Masimo iSpO2 Pulse Oximeter & EMMA Emergency Capnometer Earn JEMS Hot Products Awards at EMS Today 2013 Conference & Exposition
PR Newswire - 04/29/2013 8:00 AM ET
Masimo Steps Up with March for Babies™ to Fight for Healthier Newborns
PR Newswire - 04/26/2013 8:00 AM ET
Form 4 MASIMO CORP For: Apr 25 Filed by: McClenahan Thomas Samuel
US Securities and Exchange Commission - 04/25/2013 9:03 PM ET
Form 3 MASIMO CORP For: Apr 22 Filed by: McClenahan Thomas Samuel
US Securities and Exchange Commission - 04/25/2013 9:02 PM ET
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $21.71 USD -0.13

MASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apex Medical Corp 31.80 TWD -0.40
CONMED Corp $34.04 USD +0.50
Integra LifeSciences Holdings Corp $36.40 USD -0.11
Paramount Bed Holdings Co Ltd ¥3,375 JPY +35.00
Span-America Medical Systems Inc $18.87 USD 0.00
View Industry Companies
 

Industry Analysis

MASI

Industry Average

Valuation MASI Industry Range
Price/Earnings 20.0x
Price/Sales 2.4x
Price/Book 4.4x
Price/Cash Flow 19.5x
TEV/Sales 2.2x
View Detailed MASI Financials
 | 
View Sector Analysis

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORPORATION, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close